Stereotactic Body Radiotherapy for Frail Patients with Primary Renal Cell Carcinoma: Preliminary Results after 4 Years of Experience

Stereotactic Body Radiotherapy for Frail Patients with Primary Renal Cell Carcinoma: Preliminary Results after 4 Years of Experience

Introduction: The aim of this study was to report the oncological outcomes and toxicity of stereotactic body radiotherapy (SBRT) to treat primary renal cell carcinoma (RCC) in frail patients unfit for surgery or standard alternative ablative therapies. Methods: We retrospectively enrolled 23 patient...

Full description

Bibliographic Details
Main Authors: Laure Grelier, Michael Baboudjian, Bastien Gondran-Tellier, Anne-Laure Couderc, Robin McManus, Jean-Laurent Deville, Ana Carballeira, Raphaelle Delonca, Veronique Delaporte, Laetitia Padovani, Romain Boissier, Eric Lechevallier, Xavier Muracciole
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Cancers
Subjects:
stereotactic body radiotherapy
renal cell carcinoma
frail patients
oncological outcomes
Online Access:https://www.mdpi.com/2072-6694/13/13/3129

Internet

https://www.mdpi.com/2072-6694/13/13/3129

Similar Items